Mark C. Blaser

2.3k total citations
33 papers, 1.3k citations indexed

About

Mark C. Blaser is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Mark C. Blaser has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 15 papers in Pulmonary and Respiratory Medicine and 6 papers in Epidemiology. Recurrent topics in Mark C. Blaser's work include Cardiac Valve Diseases and Treatments (19 papers), Aortic Disease and Treatment Approaches (10 papers) and Infective Endocarditis Diagnosis and Management (6 papers). Mark C. Blaser is often cited by papers focused on Cardiac Valve Diseases and Treatments (19 papers), Aortic Disease and Treatment Approaches (10 papers) and Infective Endocarditis Diagnosis and Management (6 papers). Mark C. Blaser collaborates with scholars based in United States, Canada and United Kingdom. Mark C. Blaser's co-authors include Elena Aïkawa, Craig A. Simmons, Thomas F. Lüscher, Simon Kraler, Joshua D. Hutcheson, Krista L. Sider, Sasha A. Singh, Masanori Aikawa, Giovanni G. Camici and Florian Schlotter and has published in prestigious journals such as Circulation, Circulation Research and Advanced Drug Delivery Reviews.

In The Last Decade

Mark C. Blaser

31 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark C. Blaser United States 19 664 382 312 206 185 33 1.3k
Andrew D. Frutkin United States 14 387 0.6× 221 0.6× 307 1.0× 98 0.5× 382 2.1× 18 1.2k
Júlio Flávio Meirelles Marchini Brazil 14 196 0.3× 217 0.6× 430 1.4× 115 0.6× 195 1.1× 45 1.1k
Rebecca C. Johnson United States 7 183 0.3× 186 0.5× 228 0.7× 110 0.5× 189 1.0× 14 1.1k
C Dollery United Kingdom 11 586 0.9× 276 0.7× 302 1.0× 160 0.8× 353 1.9× 18 1.7k
Shirling Tsai United States 18 288 0.4× 508 1.3× 293 0.9× 101 0.5× 449 2.4× 84 1.2k
Pelagia Katsimbri Greece 21 281 0.4× 178 0.5× 340 1.1× 191 0.9× 139 0.8× 58 1.8k
Abbey Schepers Netherlands 21 151 0.2× 328 0.9× 341 1.1× 107 0.5× 693 3.7× 77 1.5k
J Malý Czechia 20 423 0.6× 202 0.5× 166 0.5× 78 0.4× 176 1.0× 124 1.3k
Iván Ferraz‐Amaro Spain 20 211 0.3× 158 0.4× 228 0.7× 216 1.0× 185 1.0× 144 1.5k
Ahmet Rüçhan Akar Türkiye 21 402 0.6× 176 0.5× 342 1.1× 134 0.7× 410 2.2× 76 1.3k

Countries citing papers authored by Mark C. Blaser

Since Specialization
Citations

This map shows the geographic impact of Mark C. Blaser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Blaser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Blaser more than expected).

Fields of papers citing papers by Mark C. Blaser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark C. Blaser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Blaser. The network helps show where Mark C. Blaser may publish in the future.

Co-authorship network of co-authors of Mark C. Blaser

This figure shows the co-authorship network connecting the top 25 collaborators of Mark C. Blaser. A scholar is included among the top collaborators of Mark C. Blaser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark C. Blaser. Mark C. Blaser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clift, Cassandra L., Mark C. Blaser, Francesca Bartoli‐Leonard, et al.. (2025). Sexual Dimorphism of Plasma and Tissue Proteomes in Human Calcific Aortic Valve Stenosis Pathogenesis—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 45(10). 1928–1934.
2.
Zhou, Yuqing, et al.. (2025). Ultrasound Image Velocimetry for High Spatiotemporal Resolution Blood Flow Velocity Field Mapping in Mice. Ultrasound in Medicine & Biology. 51(5). 841–851. 1 indexed citations
3.
Clift, Cassandra L., Mark C. Blaser, Mandy E. Turner, et al.. (2024). Intracellular proteomics and extracellular vesiculomics as a metric of disease recapitulation in 3D-bioprinted aortic valve arrays. Science Advances. 10(9). eadj9793–eadj9793. 10 indexed citations
4.
Villa-Roel, Nicolas, C.-S. Park, Aitor Andueza, et al.. (2024). Side- and Disease-Dependent Changes in Human Aortic Valve Cell Population and Transcriptomic Heterogeneity Determined by Single-Cell RNA Sequencing. Genes. 15(12). 1623–1623. 2 indexed citations
5.
Blaser, Mark C., Magnus Bäck, Thomas F. Lüscher, & Elena Aïkawa. (2024). Calcific aortic stenosis: omics-based target discovery and therapy development. European Heart Journal. 46(7). 620–634. 9 indexed citations
6.
Blaser, Mark C., Simon Kraler, Thomas F. Lüscher, & Elena Aïkawa. (2023). Network-Guided Multiomic Mapping of Aortic Valve Calcification. Arteriosclerosis Thrombosis and Vascular Biology. 43(3). 417–426. 10 indexed citations
7.
Rogers, Maximillian A., Francesca Bartoli‐Leonard, Kang H. Zheng, et al.. (2023). Major Facilitator Superfamily Domain Containing 5 Inhibition Reduces Lipoprotein(a) Uptake and Calcification in Valvular Heart Disease. Circulation. 149(5). 391–401. 10 indexed citations
8.
Jha, Prabhash Kumar, Mark C. Blaser, Adrien Lupieri, et al.. (2022). Prothymosin Alpha: A Novel Contributor to Estradiol Receptor Alpha–Mediated CD8 + T-Cell Pathogenic Responses and Recognition of Type 1 Collagen in Rheumatic Heart Valve Disease. Circulation. 145(7). 531–548. 23 indexed citations
9.
Kraler, Simon, Mark C. Blaser, Elena Aïkawa, Giovanni G. Camici, & Thomas F. Lüscher. (2021). Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy. European Heart Journal. 43(7). 683–697. 128 indexed citations
10.
Rogers, Maximillian A., Fabrizio Buffolo, Florian Schlotter, et al.. (2020). Annexin A1–dependent tethering promotes extracellular vesicle aggregation revealed with single–extracellular vesicle analysis. Science Advances. 6(38). 74 indexed citations
11.
Kawakami, Ryo, Shunsuke Katsuki, Richard J. Travers, et al.. (2020). S100A9-RAGE Axis Accelerates Formation of Macrophage-Mediated Extracellular Vesicle Microcalcification in Diabetes Mellitus. Arteriosclerosis Thrombosis and Vascular Biology. 40(8). 1838–1853. 63 indexed citations
12.
Goto, Shinji, Maximillian A. Rogers, Mark C. Blaser, et al.. (2019). Standardization of Human Calcific Aortic Valve Disease in vitro Modeling Reveals Passage-Dependent Calcification. Frontiers in Cardiovascular Medicine. 6. 49–49. 47 indexed citations
13.
Blaser, Mark C. & Elena Aïkawa. (2018). Roles and Regulation of Extracellular Vesicles in Cardiovascular Mineral Metabolism. Frontiers in Cardiovascular Medicine. 5. 187–187. 73 indexed citations
14.
Blaser, Mark C., Kuiru Wei, Rachel L. Adams, et al.. (2017). Deficiency of Natriuretic Peptide Receptor 2 Promotes Bicuspid Aortic Valves, Aortic Valve Disease, Left Ventricular Dysfunction, and Ascending Aortic Dilatations in Mice. Circulation Research. 122(3). 405–416. 44 indexed citations
15.
Blaser, Mark C., et al.. (2015). Biomechanical conditioning of tissue engineered heart valves: Too much of a good thing?. Advanced Drug Delivery Reviews. 96. 161–175. 47 indexed citations
16.
Sider, Krista L., Mark C. Blaser, & Craig A. Simmons. (2011). Animal Models of Calcific Aortic Valve Disease. International Journal of Inflammation. 2011. 1–18. 90 indexed citations
17.
Hannan, Johanna L., et al.. (2011). Impact of Hypertension, Aging, and Antihypertensive Treatment on the Morphology of the Pudendal Artery. The Journal of Sexual Medicine. 8(4). 1027–1038. 24 indexed citations
18.
Haines, Christopher J., et al.. (2006). Paramedic Initiated Non-Transport of Pediatric Patients. Prehospital Emergency Care. 10(2). 213–219. 37 indexed citations
19.
Nypaver, Michele M., et al.. (1994). A controlled trial of methylprednisolone in the early emergency department treatment of acute asthma in children. Pediatric Emergency Care. 10(6). 335–338. 16 indexed citations
20.
Dykewicz, Mark S., Mark C. Blaser, Richard Evans, & Roy Patterson. (1990). Pediatric Idiopathic Anaphylaxis: A Report of Three Cases with Recommendations for Evaluation and Management. Pediatric Asthma Allergy & Immunology. 4(3). 217–223. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew D. Frutkin Breakdown of academic impact, for papers by Júlio Flávio Meirelles Marchini Breakdown of academic impact, for papers by Rebecca C. Johnson Breakdown of academic impact, for papers by C Dollery Breakdown of academic impact, for papers by Shirling Tsai Breakdown of academic impact, for papers by Pelagia Katsimbri Breakdown of academic impact, for papers by Abbey Schepers Breakdown of academic impact, for papers by J Malý Breakdown of academic impact, for papers by Iván Ferraz‐Amaro Breakdown of academic impact, for papers by Ahmet Rüçhan Akar
Rankless by CCL
2026